Showing results (611-620 of 624) with videos related to

Sort By:
Pageof 63
American Journal of Human Genetics|October 27, 1997
Differential structuring of human populations for homologous X and Y microsatellite lociR Scozzari, F Cruciani, P Malaspina, et al.
Leukemia Research|June 30, 2015
Accuracy of physician assessment of treatment preferences and health status in elderly patients with higher-risk myelodysplastic syndromesG Caocci, M T Voso, E Angelucci, et al.
Leukemia|October 3, 2002
Partial deletions of long arm of chromosome 6: biologic and clinical implications in adult acute lymphoblastic leukemiaM Mancini, M L Vegna, G L Castoldi, et al.
Bone Marrow Transplantation|March 5, 1998
Autologous bone marrow transplantation for treatment of isolated central nervous system relapse of childhood acute lymphoblastic leukemia. AIEOP/FONOP-TMO group. Associzione Italiana Emato-Oncologia PediatricaC Messina, M G Valsecchi, M Aricò, et al.
Bone Marrow Transplantation|June 19, 1998
Autologous bone marrow transplantation for childhood acute lymphoblastic leukaemia in Italy. AIEOP/FONOP-TMO Group. Italian Association of Paediatric Haemato-OncologyC Messina, S Cesaro, R Rondelli, et al.
Leukemia|June 22, 2001
The prognostic value of cytogenetics is reinforced by the kind of induction/consolidation therapy in influencing the outcome of acute myeloid leukemia--analysis of 848 patientsG Visani, P Bernasconi, M Boni, et al.
Bone Marrow Transplantation|November 1, 1996
Autologous bone marrow transplantation for extramedullary relapse in childhood leukemia. The AIEOP Group and the FONOP. Italian Association of Pediatric Hemato/OncologyC Messina, R Rondelli, M G Valsecchi, et al.
Cancer Discovery|July 7, 2021
Resistance to Durvalumab and Durvalumab plus Tremelimumab Is Associated with Functional STK11 Mutations in Patients with Non-Small Cell Lung Cancer and Is Reversed by STAT3 KnockdownNabendu Pore, Song Wu, Nathan Standifer, et al.
Scientific Reports|November 24, 2018
High-throughput screens identify HSP90 inhibitors as potent therapeutics that target inter-related growth and survival pathways in advanced prostate cancerKeith H Jansson, John B Tucker, Lauren E Stahl, et al.
Leukemia|July 16, 2016
Comparative value of post-remission treatment in cytogenetically normal AML subclassified by NPM1 and FLT3-ITD allelic ratioJ Versluis, F E M In 't Hout, R Devillier, et al.
Pageof 63